India Globalization Capital, Inc.  

(Public, NYSEMKT:IGC)   Watch this stock  
Find more results for NYSEAMEX:IGC
0.450
-0.005 (-1.10%)
May 27 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.45 - 0.47
52 week 0.14 - 0.83
Open 0.45
Vol / Avg. 22,450.00/73,719.00
Mkt cap 10.59M
P/E     -
Div/yield     -
EPS -0.17
Shares 24.29M
Beta 4.32
Inst. own 1%

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -41.01% -60.98%
Operating margin -34.56% -56.54%
EBITD margin - -46.36%
Return on average assets -9.59% -24.61%
Return on average equity -12.12% -33.12%
Employees 21 -
CDP Score - -

Address

4336 Montgomery Ave
BETHESDA, MD 20814-4443
United States - Map
+1-301-9830998 (Phone)
+1-240-4650273 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

India Globalization Capital, Inc. (IGC) focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies for end of life supportive care, hospice care, and chronic neurological and oncological diagnosis. Through an overseas division it also supplies components for original equipment manufacturers (OEMs) involved in healthcare and the Internet-of-things.

Officers and directors

Ram Mukunda Executive Chairman of the Board, Chief Executive Officer, Founder
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John R. Clarke Interim Principal Financial & Accounting Officer and Treasurer
Age: 48
Bio & Compensation  - Reuters
Richard K. Prins Independent Director
Age: 57
Bio & Compensation  - Reuters
Sudhakar V. Shenoy Independent Director
Age: 67
Bio & Compensation  - Reuters